Unveiling 14 Analyst Insights On Axsome Therapeutics
Unveiling 14 Analyst Insights On Axsome Therapeutics
揭示了關於axsome therapeutics的14個分析師見解
Across the recent three months, 14 analysts have shared their insights on Axsome Therapeutics (NASDAQ:AXSM), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月中，有14位分析師分享了他們對axsome therapeutics (納斯達克: AXSM) 的見解，表達了從看好到看淡的各種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $132.14, a high estimate of $190.00, and a low estimate of $95.00. A decline of 0.18% from the prior average price target is evident in the current average.
營業收入增長：axsome therapeutics在3個月內取得了積極的成果。截至2024年6月30日，該公司實現了約86.65%的可觀營業收入增長率。這表明公司的營業收入大幅增加。與同行業相比，該公司的增長率高於醫療保健板塊同行業的平均水平。
Exploring Analyst Ratings: An In...
分析師評級...
登入免費觀看全文
登入/註冊